1. Home
  2. SCYX vs LASE Comparison

SCYX vs LASE Comparison

Compare SCYX & LASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • LASE
  • Stock Information
  • Founded
  • SCYX 1999
  • LASE 2019
  • Country
  • SCYX United States
  • LASE United States
  • Employees
  • SCYX N/A
  • LASE N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • LASE Industrial Machinery/Components
  • Sector
  • SCYX Health Care
  • LASE Industrials
  • Exchange
  • SCYX Nasdaq
  • LASE Nasdaq
  • Market Cap
  • SCYX 28.5M
  • LASE 51.8M
  • IPO Year
  • SCYX 2014
  • LASE 2022
  • Fundamental
  • Price
  • SCYX $0.70
  • LASE $2.96
  • Analyst Decision
  • SCYX
  • LASE
  • Analyst Count
  • SCYX 0
  • LASE 0
  • Target Price
  • SCYX N/A
  • LASE N/A
  • AVG Volume (30 Days)
  • SCYX 182.9K
  • LASE 470.8K
  • Earning Date
  • SCYX 08-07-2025
  • LASE 07-07-2025
  • Dividend Yield
  • SCYX N/A
  • LASE N/A
  • EPS Growth
  • SCYX N/A
  • LASE N/A
  • EPS
  • SCYX N/A
  • LASE N/A
  • Revenue
  • SCYX $2,630,000.00
  • LASE $4,962,487.00
  • Revenue This Year
  • SCYX $410.22
  • LASE N/A
  • Revenue Next Year
  • SCYX $248.83
  • LASE N/A
  • P/E Ratio
  • SCYX N/A
  • LASE N/A
  • Revenue Growth
  • SCYX N/A
  • LASE 23.87
  • 52 Week Low
  • SCYX $0.66
  • LASE $1.58
  • 52 Week High
  • SCYX $2.21
  • LASE $19.80
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 43.16
  • LASE 48.89
  • Support Level
  • SCYX $0.67
  • LASE $2.90
  • Resistance Level
  • SCYX $0.74
  • LASE $3.08
  • Average True Range (ATR)
  • SCYX 0.04
  • LASE 0.37
  • MACD
  • SCYX 0.00
  • LASE -0.05
  • Stochastic Oscillator
  • SCYX 18.79
  • LASE 6.17

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

Share on Social Networks: